jueves, 19 de marzo de 2015

Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC


Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC

Volume 21, Number 4—April 2015


Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels

Maged G. Hemida1, Abdulmohsen Al-Naeem1, Ranawaka A.P.M. Perera1, Alex W.H. Chin, Leo L.M. Poon, and Malik PeirisComments to Author 
Author affiliations: Kafrelsheikh University, Egypt (M.G. Hemida); King Faisal University, Hofuf, Saudi Arabia (M.G. Hemida, A. Al-Naeem)The University of Hong Kong, Hong Kong, China (R.A.P.M. Perera, A.W.H. Chin, L.L.M. Poon, M. Peiris)


To determine risk for Middle East respiratory syndrome coronavirus transmission from camels to humans, we tested serum from 191 persons with various levels of exposure to an infected dromedary herd. We found no serologic evidence of human infection, suggesting that zoonotic transmission of this virus from dromedaries is rare.
Cases of Middle East respiratory syndrome (MERS) in humans continue to be reported from the Arabian Peninsula and the Middle East. The largest number of cases has been reported by Saudia Arabia: 818 cases leading to 351 deaths as of December 5, 2014 (1). The causative agent is MERS coronavirus (MERS-CoV), which is endemic to and ubiquitous among dromedary camels in the Arabian Peninsula and East and North Africa; seroprevalence among adult animals is typically >90% (2). MERS-CoV infection causes mild upper respiratory illness in dromedaries and remains detectable in nasal swab specimens for ≈1 week (3).
To look for serologic evidence of MERS-CoV infection in humans extensively exposed to a herd of infected dromedaries, we assessed seroprevalence among persons in close contact with an infected herd of ≈70 animals in Al Hasa, Saudi Arabia, during peak calving season, December 2013–February 2014 (4). The study was approved by the King Faisal University Research Ethics Committee.

Dr. Hemida is an assistant professor of molecular virology at King Faisal University, Saudi Arabia. His primary research interest is virus–host interactions and the molecular biology of coronaviruses.


We thank Waleed Albu-Ali for facilitating the collection of human serum. We also thank the King Faisal University Deanship of Scientific Research (grant no. 143011) and the Area of Excellence Scheme of the Hong Kong University Grants Committee (AoE/M-12/06) of the Government of Hong Kong (Special Administrative Region of the People’s Republic of China) for research funding.


  1. Command and Control Centre, Ministry of Health, Kingdom of Saudi Arabia. 1 new confirmed corona cases recorded [cited 2014 Dec 5].http://www.moh.gov.sa/en/CCC/PressReleases/Pages/Statistics-2014-12-05-001.aspx
  2. Reusken CBMessadi LFeyisa AUlaramu HGodeke GJDanmarwa AGeographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis2014;20:13704DOIPubMed
  3. Adney DRvan Doremalen NBrown VRBushmaker TScott Dde Wit EReplication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis2014;20:19992005 . DOIPubMed
  4. Hemida MGChu DKPoon LLPerera RAAlhammadi MANg HYMERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis.2014;20:12314DOIPubMed
  5. Perera RAWang PGomaa MREl-Shesheny RKandeil ABagato OSeroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill.2013;18:20574 .PubMed
  6. Hemida MGPerera RAAl Jassim RAKayali GSiu LYWang PSeroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill2014;19:20828 .PubMed
  7. Chan RWHemida MGKayali GChu DKPoon LLAlnaeem ATropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014;2:813–22.
  8. Chu DKPoon LLGomaa MMShehata MMPerera RAAbu Zeid DMERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis.2014;20:104953DOIPubMed
  9. Alagaili ANBriese TMishra NKapoor VSameroff SCBurbelo PDMiddle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio2014;5:e0088414 . DOIPubMed
  10. Nowotny NKolodziejek JMiddle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill.2014;19:20781 .PubMed
  11. Aburizaiza ASMattes FMAzhar EIHassan AMMemish ZAMuth DInvestigation of anti–Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis2014;209:2436DOIPubMed
  12. Memish ZAAlsahly AMasri MAHeil GLAnderson BDPeiris MSparse evidence of MERS-CoV infection among animal workers living in southern Saudi Arabia during 2012. Influenza other Respir Viruses. Epub 2014 Dec 3PMID: 25470665 DOI
  13. Sims LDPeiris MOne Health: the Hong Kong experience with avian influenza. Curr Top Microbiol Immunol2013;365:28198 . DOIPubMed
  14. Horby PNguyen NYDunstan SJBaillie JKThe role of host genetics in susceptibility to influenza: a systematic review. PLoS ONE2012;7:e33180.DOIPubMed
Suggested citation for this article: Hemida MG, Al-Naeem A, Perera RAPM, Chin AWH, Poon LLM, Peiris M. Lack of Middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis. 2015 Apr [date cited]. http://dx.doi.org/10.3201/eid2104.141949
DOI: 10.3201/eid2104.141949
1These authors contributed equally to this article.

No hay comentarios:

Publicar un comentario